- Title: Subtitle
- Talquetamab in B Cell Maturation Antigen (BCMA) Exposed Relapsed-Refractory Multiple Myeloma Patients
- Creators
- Hira Shaikh - University of IowaJonathan Lochner - University of IowaBradley Loeffler - University of IowaReed Friend - Levine Cancer InstituteAlma Habib - The Ohio State UniversityMarshall McKenna - Rutgers, The State University of New JerseyJordan Snyder - University of Kansas Medical CenterJames A Davis - Medical University of South CarolinaGina Patrus - Allegheny Health NetworkRachel Dileo - Allegheny Health NetworkPrerna Mewawalla - Allegheny Health NetworkKimberly M Green - Medical University of South CarolinaMuhammad Umair Mushtaq - University of Kansas Medical CenterChristopher Strouse - University of IowaYun Kyoung Tiger - Rutgers, The State University of New JerseyAl-Ola Abdallah - University of Kansas Medical CenterNausheen Ahmed - University of Kansas Medical CenterAbdullah Mohammad Khan - The Ohio State UniversityHamza Hashmi - Medical University of South CarolinaBarry Paul - Levine Cancer InstituteShebli Atrash - Wake Forest University
- Resource Type
- Abstract
- Publication Details
- Blood, Vol.144(Supplement 1), pp.5170-5170.4
- DOI
- 10.1182/blood-2024-211018
- ISSN
- 0006-4971
- eISSN
- 1528-0020
- Language
- English
- Date published
- 11/05/2024
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9984770792902771
Abstract
Talquetamab in B Cell Maturation Antigen (BCMA) Exposed Relapsed-Refractory Multiple Myeloma Patients
Blood, Vol.144(Supplement 1), pp.5170-5170.4
11/05/2024
DOI: 10.1182/blood-2024-211018
Details
Metrics
11 Record Views